Bruker Statistics
Total Valuation
Bruker has a market cap or net worth of $8.09 billion. The enterprise value is $10.41 billion.
| Market Cap | 8.09B |
| Enterprise Value | 10.41B |
Important Dates
The last earnings date was Tuesday, November 5, 2024, before market open.
| Earnings Date | Nov 5, 2024 |
| Ex-Dividend Date | Aug 30, 2024 |
Share Statistics
Bruker has 151.60 million shares outstanding. The number of shares has increased by 0.34% in one year.
| Current Share Class | 151.60M |
| Shares Outstanding | 151.60M |
| Shares Change (YoY) | +0.34% |
| Shares Change (QoQ) | +2.70% |
| Owned by Insiders (%) | 31.91% |
| Owned by Institutions (%) | 78.30% |
| Float | 103.13M |
Valuation Ratios
The trailing PE ratio is 25.89 and the forward PE ratio is 20.70. Bruker's PEG ratio is 1.42.
| PE Ratio | 25.89 |
| Forward PE | 20.70 |
| PS Ratio | 2.43 |
| Forward PS | 2.28 |
| PB Ratio | 4.48 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 51.63 |
| P/OCF Ratio | 30.33 |
| PEG Ratio | 1.42 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.87, with an EV/FCF ratio of 66.46.
| EV / Earnings | 34.16 |
| EV / Sales | 3.21 |
| EV / EBITDA | 18.87 |
| EV / EBIT | 27.14 |
| EV / FCF | 66.46 |
Financial Position
The company has a current ratio of 1.66, with a Debt / Equity ratio of 1.33.
| Current Ratio | 1.66 |
| Quick Ratio | 0.66 |
| Debt / Equity | 1.33 |
| Debt / EBITDA | 4.13 |
| Debt / FCF | 15.60 |
| Interest Coverage | 10.46 |
Financial Efficiency
Return on equity (ROE) is 19.73% and return on invested capital (ROIC) is 7.09%.
| Return on Equity (ROE) | 19.73% |
| Return on Assets (ROA) | 4.83% |
| Return on Capital (ROIC) | 7.09% |
| Revenue Per Employee | $333,914 |
| Profits Per Employee | $31,410 |
| Employee Count | 9,707 |
| Asset Turnover | 0.65 |
| Inventory Turnover | 1.52 |
Taxes
In the past 12 months, Bruker has paid $87.80 million in taxes.
| Income Tax | 87.80M |
| Effective Tax Rate | 22.38% |
Stock Price Statistics
The stock price has decreased by -12.91% in the last 52 weeks. The beta is 1.20, so Bruker's price volatility has been higher than the market average.
| Beta (5Y) | 1.20 |
| 52-Week Price Change | -12.91% |
| 50-Day Moving Average | 61.81 |
| 200-Day Moving Average | 71.03 |
| Relative Strength Index (RSI) | 40.73 |
| Average Volume (20 Days) | 1,571,298 |
Short Selling Information
The latest short interest is 3.81 million, so 2.51% of the outstanding shares have been sold short.
| Short Interest | 3.81M |
| Short Previous Month | 4.34M |
| Short % of Shares Out | 2.51% |
| Short % of Float | 3.69% |
| Short Ratio (days to cover) | 3.34 |
Income Statement
In the last 12 months, Bruker had revenue of $3.24 billion and earned $304.90 million in profits. Earnings per share was $2.06.
| Revenue | 3.24B |
| Gross Profit | 1.62B |
| Operating Income | 383.70M |
| Pretax Income | 455.90M |
| Net Income | 304.90M |
| EBITDA | 551.90M |
| EBIT | 383.70M |
| Earnings Per Share (EPS) | $2.06 |
Balance Sheet
The company has $157.10 million in cash and $2.44 billion in debt, giving a net cash position of -$2.29 billion or -$15.09 per share.
| Cash & Cash Equivalents | 157.10M |
| Total Debt | 2.44B |
| Net Cash | -2.29B |
| Net Cash Per Share | -$15.09 |
| Equity (Book Value) | 1.84B |
| Book Value Per Share | 11.92 |
| Working Capital | 869.30M |
Cash Flow
In the last 12 months, operating cash flow was $266.80 million and capital expenditures -$110.10 million, giving a free cash flow of $156.70 million.
| Operating Cash Flow | 266.80M |
| Capital Expenditures | -110.10M |
| Free Cash Flow | 156.70M |
| FCF Per Share | $1.03 |
Margins
Gross margin is 49.95%, with operating and profit margins of 11.84% and 9.41%.
| Gross Margin | 49.95% |
| Operating Margin | 11.84% |
| Pretax Margin | 12.10% |
| Profit Margin | 9.41% |
| EBITDA Margin | 17.03% |
| EBIT Margin | 11.84% |
| FCF Margin | 5.43% |
Dividends & Yields
This stock pays an annual dividend of $0.20, which amounts to a dividend yield of 0.37%.
| Dividend Per Share | $0.20 |
| Dividend Yield | 0.37% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 9.70% |
| Buyback Yield | -0.34% |
| Shareholder Yield | 0.04% |
| Earnings Yield | 3.77% |
| FCF Yield | 1.94% |
Analyst Forecast
The average price target for Bruker is $77.45, which is 45.12% higher than the current price. The consensus rating is "Buy".
| Price Target | $77.45 |
| Price Target Difference | 45.12% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (5Y) | 8.74% |
| EPS Growth Forecast (5Y) | 9.62% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Bruker has an Altman Z-Score of 2.89 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.89 |
| Piotroski F-Score | 3 |